Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 2Lung Neoplasms 1Digestive System Diseases 1Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors 1Chemotherapy-induced Thrombocytopenia 1Chemotherapy Induced Thrombocytopenia 1Cancer Therapy-induced Thrombocytopenia (CTIT) 1Breast Neoplasms 1

Interventions

Oxaliplatin 3Ocoxin 3pembrolizumab 2Capecitabine 2penpulimab 1hetrombopag 1golotimod 1durvalumab 1camrelizumab 1aumolertinib 1alectinib 1XELOX 1Surgical Procedures, Operative 1Sunitinib 1Radiotherapy 1Paclitaxel 1Nivolumab 1Immunotherapy 1Imatinib Mesylate 1HhAntag691 1Gemcitabine 1Fluorouracil 1Cyclophosphamide 1Chemoradiotherapy 1Ascorbic Acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Digestive System Diseases × hetrombopag × Clear all
NCT05442632 2024-03-13

Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy

Fudan University

Phase 2 Unknown
96 enrolled
Classical hematology

Digestive System Diseases, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡